She is the general manager of Pfizer in Mexico, a pharmaceutical company that in the last four years has invested US$49 million in research and development in the country. This year, she is preparing the arrival of oncology and migraine drugs in Mexico. Losada was appointed president of the Mexican Association of Pharmaceutical Research Industries in 2023.
